Molecular Therapy
Volume 25, Issue 1, 4 January 2017, Pages 285-295
Original ArticlePhase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Under a Creative Commons license
open access
Keywords
CAR T
CD19
diffuse large B cell lymphoma
refractory NHL
KTE-C19
Cited by (0)
- 8
These authors contributed equally to this work.
© 2016 The Authors.